Zucapride 5 Tab

Tablet

Treatment of functional dyspepsia (indigestion), gastroesophageal reflux disease (GERD) symptoms, gastroparesis/delayed gastric emptying, nausea, bloating and early satiety associated with gastric motility disorders

Mosapride is a prokinetic agent that selectively stimulates 5-HT4 receptors in the gastrointestinal tract, enhancing acetylcholine release. This increases gastric and intestinal motility and improves gastric emptying, helping relieve symptoms like bloating, nausea and reflux.

Take as directed by the physician. Common adult use is 5 mg tablet taken 2–3 times daily before meals; swallow whole with water. Use at the same time each day; do not exceed the prescribed dose.

Diarrhea, abdominal pain/cramps, nausea, headache, dizziness, dry mouth, constipation

Use with caution in patients with severe liver impairment, history of arrhythmias or electrolyte disturbances. Seek medical advice if you develop palpitations, fainting, severe diarrhea, or allergic reactions. Not recommended for self-medication for persistent GI symptoms; evaluate for obstruction or serious disease if symptoms persist.

QT-prolonging medicines (e.g., certain antiarrhythmics, antipsychotics, macrolides, fluoroquinolones), strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir), other prokinetics or drugs affecting GI motility, anticholinergics may reduce effect

Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.

Mosarid 5 Tablet, Mosapride 5 mg Tablet (generic), Mospit 5 Tablet, Mosday 5 Tablet, Mosride 5 Tablet